FDA Inspection 845560 — Catalent Greenville Inc
The FDA completed an inspection of Catalent Greenville Inc on August 21, 2013 in Greenville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Greenville, NC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)